Scaling is fully physiologic: F and V (or Vd×weight) define (S=1000,F/V) converting model mg → ng/mL. CR = biphasic (IR + delayed pulse or plateau). Lisdexamfetamine models LDX absorption, enzymatic conversion (first-order), and AMP elimination; “Yield” scales mg AMP per mg LDX.
About this theoretical pharmacokinetic simulator
This open educational tool visualizes idealized stimulant pharmacokinetic concentration-time curves under simplified, deterministic assumptions so you can experiment with release patterns and elimination half-lives.
Adjust dose, uptake shape (k), mean transit time (MTT),
lags, fractions and half-lives and see immediate effects on the
modeled curve (relative ng/mL scale). Concentrations scale via C =
(1000·F/V)·A using either Vd×weight or absolute V.
Methylphenidate (MPH) here covers immediate-release (IR), biphasic controlled-release (CR) and OROS osmotic formulations. Modeling: IR is idealized as a single gamma-distributed uptake pulse. CR is modeled as IR + a delayed component that you can set either as a second gamma pulse or as a quasi-constant “plateau” infusion (for Spansule-like behavior). OROS is modeled as a small IR fraction plus a quasi-constant pump window. Lisdexamfetamine (LDX) is modeled as a prodrug: a single uptake (LDX absorption) followed by first-order enzymatic conversion to d-amphetamine and separate d-amphetamine elimination. Only abstract concentration-time kinetics are represented - no pharmacodynamic effects are simulated.
For specific questions (model types, scaling, variability limits, exporting) see the FAQ below. The intent is conceptual understanding - not clinical guidance.
Disclaimer: Not medical advice. Do not use for diagnosis, treatment, dosing, or timing decisions.
Frequently asked questions
Is this tool medical advice?
What does the model simulate?
Does it include variability or personalized metabolism?
Can I export and share my scenarios?
How are concentrations scaled?
What do IR, CR and OROS mean?
Methylphenidate IR = Immediate Release (single uptake pulse).
Methylphenidate CR (biphasic) = Controlled Release with a fast IR fraction followed by a delayed component that can be either a second gamma pulse or a plateau-style infusion, approximating biphasic products.
Methylphenidate OROS = Osmotic Release Oral System: small IR fraction plus a near-constant (configurable shape) pump-driven release over a defined window.